Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain
- PMID: 17446303
- DOI: 10.1124/jpet.107.121228
Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain
Abstract
We investigated the effects of chronic nicotine on alpha6- and beta3-containing nicotinic acetylcholine receptors (nAChRs) in two rat brain regions using three methodological approaches: radioligand binding, immunoprecipitation, and nicotine-stimulated synaptosomal release of dopamine. Nicotine was administered by osmotic minipumps for 2 weeks. Quantitative autoradiography with [(125)I]alpha-conotoxin MII to selectively label alpha6(*) nAChRs showed a 28% decrease in binding in the striatum but no change in the superior colliculus. Immunoprecipitation of nAChRs labeled by [(3)H]epibatidine in these two regions showed that chronic nicotine increased alpha4- and beta2-containing nAChRs by 39 to 67%. In contrast, chronic nicotine caused a 39% decrease in alpha6-containing nAChRs in striatum but no change in superior colliculus. No changes in beta3-containing nAChRs were seen in either region after chronic nicotine. The decreased expression of alpha6-containing nAChRs persisted for at least 3 days, recovering to baseline by 7 days after removal of the pumps. There was a small but significant decrease in total nicotine-stimulated dopamine release in striatal synaptosomes after nicotine exposure. However, the component of dopamine release that was resistant to alpha-conotoxin MII blockade was unaffected, whereas dopamine release that was sensitive to blockade by alpha-conotoxin MII was decreased by 56%. These findings indicate that the alpha6(*) nAChR is regulated differently from other nAChR subtypes, and they suggest that the inclusion of a beta3 subunit with alpha6 may serve to inhibit nicotine-induced down-regulation of these receptors.
Similar articles
-
Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.Mol Pharmacol. 2006 Sep;70(3):967-76. doi: 10.1124/mol.106.024513. Epub 2006 May 30. Mol Pharmacol. 2006. PMID: 16735605
-
Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice.Mol Pharmacol. 2007 Jun;71(6):1563-71. doi: 10.1124/mol.106.031492. Epub 2007 Mar 6. Mol Pharmacol. 2007. PMID: 17341654
-
Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.Neuroscience. 2006;137(2):565-72. doi: 10.1016/j.neuroscience.2005.09.008. Epub 2005 Nov 14. Neuroscience. 2006. PMID: 16289885
-
Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy.J Pharmacol Exp Ther. 2006 Feb;316(2):481-9. doi: 10.1124/jpet.105.094375. Epub 2005 Oct 6. J Pharmacol Exp Ther. 2006. PMID: 16210393 Review.
-
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.Biochem Pharmacol. 2007 Oct 15;74(8):1235-46. doi: 10.1016/j.bcp.2007.07.032. Epub 2007 Jul 27. Biochem Pharmacol. 2007. PMID: 17825262 Free PMC article. Review.
Cited by
-
Inside-out neuropharmacology of nicotinic drugs.Neuropharmacology. 2015 Sep;96(Pt B):178-93. doi: 10.1016/j.neuropharm.2015.01.022. Epub 2015 Feb 4. Neuropharmacology. 2015. PMID: 25660637 Free PMC article. Review.
-
Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.J Pharmacol Exp Ther. 2012 Nov;343(2):441-50. doi: 10.1124/jpet.112.198085. Epub 2012 Aug 16. J Pharmacol Exp Ther. 2012. PMID: 22899752 Free PMC article.
-
Quantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampus.J Neurochem. 2010 Nov;115(3):625-34. doi: 10.1111/j.1471-4159.2010.06967.x. Epub 2010 Sep 27. J Neurochem. 2010. PMID: 20796176 Free PMC article.
-
Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.Biochem Pharmacol. 2010 Aug 1;80(3):402-9. doi: 10.1016/j.bcp.2010.03.018. Epub 2010 Mar 25. Biochem Pharmacol. 2010. PMID: 20346923 Free PMC article.
-
Neurobiological Mechanisms of Nicotine Reward and Aversion.Pharmacol Rev. 2022 Jan;74(1):271-310. doi: 10.1124/pharmrev.121.000299. Pharmacol Rev. 2022. PMID: 35017179 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources